Elevation of glutathione in RAW 264.7 cells by low-dose γ-ray irradiation and its responsibility for the appearance of radioresistance

Shuji Kojima, Shirane Matsumori, Hideki Ono, Kiyonori Yamaoka

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

We examined the relationship between the induction of glutathione (GSH) level in macrophage-like RAW264.7 cells by a low (adapting) dose γ-rays and the cell damage caused by a lethal dose of γ-rays at various intervals after the adapting dose. The reduced glutathione (GSH) level increased soon after exposure of the cells to 25 cGy of γ-rays, peaked between 3 hr and 6 hr, and returned almost to the zero time (0 hr) level by 24 hr post-irradiation. Cell damage was assessed by measuring the 3H-thymidine (3H-TdR) incorporation into cellular DNA. γ-Ray irradiation produced a dose-dependent cell damage in RAW cells, causing about 40% and 60% inhibition of 3H-TdR incorporation into DNA at 1.0 Gy and 2.0 Gy, respectively, as compared with non-irradiated cells. Treatment with the adapting dose of 25 cGy at 1 hr or 24 hr before the lethal irradiation was ineffective. However, pre-irradiation with 25 cGy at 3 hr or 6 hr prior to lethal irradiation inhibited the decrease of 3H-TdR incorporation into DNA, indicating a protective effect. GSH exogenously added to the medium also inhibited the cell damage induced by lethal doses of γ-Rays in a dose-dependent manner. These results indicate that the induction of endogenous GSH in living cells immediately following low-dose γ-Ray irradiation is at least partially responsible for the appearance of radioresistance to a subsequent lethal dose of radiation, and may make it possible to use higher doses of radiation in radiotherapy for tumor patients.

Original languageEnglish
Pages (from-to)5271-5275
Number of pages5
JournalAnticancer Research
Volume19
Issue number6 B
Publication statusPublished - Nov 1999

Fingerprint

Glutathione
DNA
Radiation
RAW 264.7 Cells
Thymidine
Radiotherapy
Macrophages
Neoplasms

Keywords

  • Glutathione
  • Low-dose γ-ray
  • Radioresistance
  • RAW 264.7 cells

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Elevation of glutathione in RAW 264.7 cells by low-dose γ-ray irradiation and its responsibility for the appearance of radioresistance. / Kojima, Shuji; Matsumori, Shirane; Ono, Hideki; Yamaoka, Kiyonori.

In: Anticancer Research, Vol. 19, No. 6 B, 11.1999, p. 5271-5275.

Research output: Contribution to journalArticle

@article{3c0818102ea743868a63e9acdea66934,
title = "Elevation of glutathione in RAW 264.7 cells by low-dose γ-ray irradiation and its responsibility for the appearance of radioresistance",
abstract = "We examined the relationship between the induction of glutathione (GSH) level in macrophage-like RAW264.7 cells by a low (adapting) dose γ-rays and the cell damage caused by a lethal dose of γ-rays at various intervals after the adapting dose. The reduced glutathione (GSH) level increased soon after exposure of the cells to 25 cGy of γ-rays, peaked between 3 hr and 6 hr, and returned almost to the zero time (0 hr) level by 24 hr post-irradiation. Cell damage was assessed by measuring the 3H-thymidine (3H-TdR) incorporation into cellular DNA. γ-Ray irradiation produced a dose-dependent cell damage in RAW cells, causing about 40{\%} and 60{\%} inhibition of 3H-TdR incorporation into DNA at 1.0 Gy and 2.0 Gy, respectively, as compared with non-irradiated cells. Treatment with the adapting dose of 25 cGy at 1 hr or 24 hr before the lethal irradiation was ineffective. However, pre-irradiation with 25 cGy at 3 hr or 6 hr prior to lethal irradiation inhibited the decrease of 3H-TdR incorporation into DNA, indicating a protective effect. GSH exogenously added to the medium also inhibited the cell damage induced by lethal doses of γ-Rays in a dose-dependent manner. These results indicate that the induction of endogenous GSH in living cells immediately following low-dose γ-Ray irradiation is at least partially responsible for the appearance of radioresistance to a subsequent lethal dose of radiation, and may make it possible to use higher doses of radiation in radiotherapy for tumor patients.",
keywords = "Glutathione, Low-dose γ-ray, Radioresistance, RAW 264.7 cells",
author = "Shuji Kojima and Shirane Matsumori and Hideki Ono and Kiyonori Yamaoka",
year = "1999",
month = "11",
language = "English",
volume = "19",
pages = "5271--5275",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "6 B",

}

TY - JOUR

T1 - Elevation of glutathione in RAW 264.7 cells by low-dose γ-ray irradiation and its responsibility for the appearance of radioresistance

AU - Kojima, Shuji

AU - Matsumori, Shirane

AU - Ono, Hideki

AU - Yamaoka, Kiyonori

PY - 1999/11

Y1 - 1999/11

N2 - We examined the relationship between the induction of glutathione (GSH) level in macrophage-like RAW264.7 cells by a low (adapting) dose γ-rays and the cell damage caused by a lethal dose of γ-rays at various intervals after the adapting dose. The reduced glutathione (GSH) level increased soon after exposure of the cells to 25 cGy of γ-rays, peaked between 3 hr and 6 hr, and returned almost to the zero time (0 hr) level by 24 hr post-irradiation. Cell damage was assessed by measuring the 3H-thymidine (3H-TdR) incorporation into cellular DNA. γ-Ray irradiation produced a dose-dependent cell damage in RAW cells, causing about 40% and 60% inhibition of 3H-TdR incorporation into DNA at 1.0 Gy and 2.0 Gy, respectively, as compared with non-irradiated cells. Treatment with the adapting dose of 25 cGy at 1 hr or 24 hr before the lethal irradiation was ineffective. However, pre-irradiation with 25 cGy at 3 hr or 6 hr prior to lethal irradiation inhibited the decrease of 3H-TdR incorporation into DNA, indicating a protective effect. GSH exogenously added to the medium also inhibited the cell damage induced by lethal doses of γ-Rays in a dose-dependent manner. These results indicate that the induction of endogenous GSH in living cells immediately following low-dose γ-Ray irradiation is at least partially responsible for the appearance of radioresistance to a subsequent lethal dose of radiation, and may make it possible to use higher doses of radiation in radiotherapy for tumor patients.

AB - We examined the relationship between the induction of glutathione (GSH) level in macrophage-like RAW264.7 cells by a low (adapting) dose γ-rays and the cell damage caused by a lethal dose of γ-rays at various intervals after the adapting dose. The reduced glutathione (GSH) level increased soon after exposure of the cells to 25 cGy of γ-rays, peaked between 3 hr and 6 hr, and returned almost to the zero time (0 hr) level by 24 hr post-irradiation. Cell damage was assessed by measuring the 3H-thymidine (3H-TdR) incorporation into cellular DNA. γ-Ray irradiation produced a dose-dependent cell damage in RAW cells, causing about 40% and 60% inhibition of 3H-TdR incorporation into DNA at 1.0 Gy and 2.0 Gy, respectively, as compared with non-irradiated cells. Treatment with the adapting dose of 25 cGy at 1 hr or 24 hr before the lethal irradiation was ineffective. However, pre-irradiation with 25 cGy at 3 hr or 6 hr prior to lethal irradiation inhibited the decrease of 3H-TdR incorporation into DNA, indicating a protective effect. GSH exogenously added to the medium also inhibited the cell damage induced by lethal doses of γ-Rays in a dose-dependent manner. These results indicate that the induction of endogenous GSH in living cells immediately following low-dose γ-Ray irradiation is at least partially responsible for the appearance of radioresistance to a subsequent lethal dose of radiation, and may make it possible to use higher doses of radiation in radiotherapy for tumor patients.

KW - Glutathione

KW - Low-dose γ-ray

KW - Radioresistance

KW - RAW 264.7 cells

UR - http://www.scopus.com/inward/record.url?scp=0033387454&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033387454&partnerID=8YFLogxK

M3 - Article

C2 - 10697548

AN - SCOPUS:0033387454

VL - 19

SP - 5271

EP - 5275

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 6 B

ER -